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T follicular helper (Tfh) cells are critically involved in the establishment of potent antibody 
responses against infectious pathogens, such as viruses and bacteria, but their dys-
regulation may also result in aberrant antibody responses that frequently coincide with 
autoimmune diseases or allergies. The fate and identity of Tfh cells is tightly controlled 
by gene regulation on the transcriptional and posttranscriptional level. Here, we provide 
deeper insights into the posttranscriptional mechanisms that regulate Tfh cell differ-
entiation, function, and plasticity through the actions of RNA-binding proteins (RBPs) 
and small endogenously expressed regulatory RNAs called microRNAs (miRNAs). 
The Roquin family of RBPs has been shown to dampen spontaneous activation and 
differentiation of naïve CD4+ T cells into Tfh cells, since CD4+ T cells with Roquin muta-
tions accumulate as Tfh cells and provide inappropriate B cell help in the production 
of autoantibodies. Moreover, Regnase-1, an endoribonuclease that regulates a set of 
targets, which strongly overlaps with that of Roquin, is crucial for the prevention of auto-
antibody production. Interestingly, both Roquin and Regnase-1 proteins are cleaved and 
inactivated after TCR stimulation by the paracaspase MALT1. miRNAs are expressed 
in naïve CD4+ T cells and help preventing spontaneous differentiation into effector cells. 
While most miRNAs are downregulated upon T cell activation, several miRNAs have 
been shown to regulate the fate of these cells by either promoting (e.g., miR-17–92 and 
miR-155) or inhibiting (e.g., miR-146a) Tfh cell differentiation. Together, these different 
aspects highlight a complex and dynamic regulatory network of posttranscriptional gene 
regulation in Tfh cells that may also be active in other T helper cell populations, including 
Th1, Th2, Th17, and Treg.
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iNTRODUCTiON
T helper cells are important constituents of the adaptive immune system. They are critically 
involved in the elimination of various pathogens, including viruses, bacteria, and fungi. Due to 
their capabilities of forming immunological memory and providing help to B cells, vaccines aim at 
inducing strong T helper cell responses in concert with cytotoxic T cells and antibody-producing 
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B  cells. However, dysregulated T helper cell responses are also 
associated with several diseases. In allergies, the immune system 
reacts to normally innocuous compounds of the environment. In 
autoimmune diseases such as type I diabetes, multiple sclerosis, 
and rheumatoid arthritis, T helper cells are coordinating critical 
processes that contribute to tissue inflammation and destruction. 
In cancer, dysregulated T helper cells might on the one hand be 
impaired in their proper functioning, thus limiting the body’s 
immune response against neoplastic cells and tissues. On the 
other hand, hyper-responsiveness or malignant transformation 
of T helper cells can drive chronic inflammation or induce neo-
plasia, respectively.
T helper cells comprise many different subsets that are each 
tailored to the functional response that these cells elicit against 
various different pathogens. The major T helper cell subsets 
include Th1, Th2, Th17, T follicular helper (Tfh), and regulatory 
T (Treg) cells, which can be differentiated by their characteristic 
expression of signature transcription factors, chemokine recep-
tors, and cytokines (1). While initially it was believed that Th2 
cells provide help to B cells, it is now accepted that Tfh cells are 
the major subset of T helper cells that is specialized in providing 
help to B cells for the establishment and maintenance of germinal 
centers (GCs) and for the production of high-affinity antibodies 
(2–4). In line with this, Tfh cells express the chemokine recep-
tor CXCR5, which facilitates the migration of activated CD4+ 
T cells to the T-B zone border and further into the B cell follicle. 
This aspect also reflects the step-wise differentiation process of 
Tfh cells, which are initially primed by dendritic cells, followed 
by sequential interactions with activated B cells and GC B cells 
(2–4). Tfh cells produce various cytokines, including IL-21 and 
IL-4, and they express several costimulatory molecules, including 
ICOS, CD40L, and PD-1, which allow for reciprocal interactions 
with B cells. Tfh cells are further characterized by the expression 
of the transcription factors Ascl2 and Bcl6, and the adaptor 
molecule SAP. Besides Tfh cells, T follicular regulatory (Tfr) cells 
have been identified as a hybrid cell population of Tfh and Treg 
cells that prevent excessive humoral immune responses (5). They 
express the signature transcription factors of Tfh and Treg cells, 
Bcl6 and Foxp3, respectively, and share additional characteristics 
of both T helper cell subsets.
The differentiation of naïve CD4+ T  cells into effector and 
memory cells is tightly regulated on the molecular level (6–8). 
Several signature or “master” transcription factors have been 
identified that are specific for the respective T helper cell subset, 
e.g., T-bet for Th1, Gata-3 for Th2, RORγt for Th17, Bcl6 for Tfh, 
and Foxp3 for Treg. Often, these transcription factors also inhibit 
each other’s function, thus contributing to cell fate decisions of 
the differentiating cells. Upstream of these “lineage”-defining 
transcription factors, combinations of Jak (Janus kinase) and sig-
nal transducer and activator of transcription (STAT) molecules 
that transduce signaling events from cytokine receptors have 
also been associated with the different T helper cell populations 
(9). Given the variety of T helper cell qualities, gene expression 
needs to be thoroughly regulated in activated CD4+ T  cells to 
ensure proper differentiation into the different T helper cell 
subsets (10). Beside the direct transcriptional regulation through 
STATs and other transcription factors, transcribed mRNAs are 
furthermore highly regulated on the posttranscriptional level. 
Several mechanisms contribute to this regulation, including 
RNA-binding proteins (RBPs) and microRNAs (miRNAs), which 
can act cooperatively on different as well as on similar molecular 
pathways. In this review, we discuss the role of different RBPs and 
miRNAs in shaping Tfh cell identity and function.
POSTTRANSCRiPTiONAL GeNe 
ReGULATiON BY RBPs iN T CeLLS
RNA-binding proteins are trans-acting factors that interact 
with specific cis-elements in RNAs by recognizing linear 
sequence motifs or dynamically forming secondary structures. 
The binding to cis-elements in the 5′ UTR typically controls 
translation initiation, while binding to sites in the 3′ UTRs 
of transcripts typically regulates mRNA decay or translation 
efficiency (11).
The Roquin family of RBPs includes the paralogs Roquin-1 
and Roquin-2. These proteins are encoded by the Rc3h1 
and Rc3h2 genes and serve redundant functions in T  cells 
(12–14). The Regnase family comprises the paralogs Regnase-1, 
Regnase-2, Regnase-3, and Regnase-4 also known as Mcpip1, 2, 
3, and 4, which are encoded by the Zc3h12a, Zc3h12b, Zc3h12c, 
and Zc3h12d genes (15). The redundancy of Regnase proteins 
has not been addressed experimentally; however, Regnase-1 
and Regnase-4 proteins appear to be the T cell-expressed para-
logs (15). Regnase-1 and Roquin proteins predominantly bind 
to 3′ UTRs of mRNAs (16, 17) and play important roles in the 
regulation of T cell fate decisions (14, 18–22). Roquin proteins 
recognize stem-loop structures of the tri- or hexa-loop contain-
ing CDE or ADE consensus motifs, respectively (17, 23–30). 
These interactions allow the recruitment of mRNA degrading 
enzymes (24, 31, 32) and induce decay of target mRNAs. 
Regnase-1 also appears to repress targets through similar stem-
loop structures (16, 21, 33, 34) that are present in an overlapping 
set of target mRNAs with pro-inflammatory functions (16, 20). 
However, the endonuclease Regnase-1 may rather cleave target 
mRNAs itself or, dependent on the 3′ UTR, induce translational 
inhibition (16, 21, 33–35). Among the well-established targets 
of Roquin and Regnase proteins are ICOS, Ox40, Il6, cRel, 
Irf4, Nfkbiz, and Nfkbid (14, 16–24, 28, 33, 34). Interestingly, 
the mRNAs encoding for Roquin and Regnase proteins them-
selves contain cis-elements that enable the system to fine-tune 
expression levels through negative autoregulation (18, 20, 24, 
27, 33). However, it is currently under debate whether these 
factors cooperate in posttranscriptional gene regulation or work 
independently in a spatially and temporally compartmentalized 
fashion (16, 20, 36, 37).
While Roquin-1 and the less abundant Roquin-2 proteins 
show rather constitutive expression in T cells (14) and are only 
moderately upregulated in response to TCR-dependent T  cell 
stimulation (38), the most prominent member of the Regnase 
family of proteins in T cells, Regnase-1, is weakly expressed in 
naive T cells, but becomes induced during TCR-dependent acti-
vation of T cells (39) (Figure 1). However, during TCR signaling 
itself, Roquin-1 and Roquin-2 as well as Regnase-1 proteins are 
Naive TCRstimulation
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Roquin-2
(Full-length
proteins)
Regnase-1
(Full-length
protein)
miRISC
(Pan-Ago
proteins)
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miR-17~92
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miR-146
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miR-155
FiGURe 1 | Expression kinetics of major RNA-binding proteins and 
microRNAs (miRNAs) during T helper cell differentiation. Abbreviations: 
miRISC, miRNA-induced silencing complex; Ago, Argonaute.
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cleaved and functionally inactivated by the MALT1 paracaspase 
(20, 21, 40) (Figure 1).
RNA-BiNDiNG PROTeiN-MeDiATeD 
ReGULATiON OF Tfh AND Tfr CeLLS
The Roquin and Regnase-1 RBPs have been shown to be 
involved in the regulation of the GC reaction and prevention 
of autoimmunity, since mutation or loss-of-function of the 
encoding genes lead to spontaneous activation of T cells and the 
development of antinuclear antibodies in mice (14, 18, 20–22). 
Their role in Tfh and Tfr cells will be described in more detail 
here (Figure 2).
ROQUiN
The gene encoding for Roquin-1 was identified in the lab of 
Christopher Goodnow by screening of mice for ethyl nitroso 
urea-induced mutations that caused the formation of antinuclear 
autoantibodies (22). Homozygous mutation exchanging one 
single amino acid of M199R in Roquin-1, as determined in the 
so-called sanroque mouse strain, was found to cause a dramatic 
activation of CD8+ and CD4+ T cells and led to the accumulation 
of Tfh cells. Spleens of these mice contained large numbers of 
GCs and the induced GC B cells produced high-affinity antibod-
ies against a large variety of self-antigens (22, 41). Surprisingly, 
the knockout of the Roquin-1-encoding gene Rc3h1 showed 
postnatal lethality and mild immune dysregulation but did not 
recapitulate the flagrant autoimmune phenotype of sanroque mice 
(42). Nevertheless, combined deletion of Roquin-1 and Roquin-2 
encoding genes in T cells resulted in the spontaneous activation 
of CD4+ and CD8+ T cells and the accumulation of Tfh cells and 
GC B cells. These findings demonstrated redundant functions of 
both proteins in T cells and suggested a compensatory function 
of the much lower expressed Roquin-2 protein in the absence of 
Roquin-1, but not when Roquin-1san protein is expressed (14). In 
mice lacking Roquin-1 and Roquin-2-encoding alleles in T cells, 
the splenic architecture was greatly disturbed and, as a probable 
consequence, less self-reactive antibodies were observed in the 
sera (14, 20).
The molecular mechanisms underlying spontaneous T  cell 
activation and Tfh cell differentiation are likely to involve several 
Roquin-regulated targets that synergize in this differentiation 
program. Initially, the dysregulation of ICOS, the first and best-
studied Roquin target (22, 28, 31, 38, 43, 44), was proposed to 
explain the observed autoimmune phenotype (45). However, 
sanroque mice that were additionally deficient in Icos were later 
shown to maintain many phenotypes including Tfh cell accumula-
tion (46). Instead, accumulation of Tfh cells in sanroque mice was 
a consequence of the excessive production of IFN-γ that occurs in 
these mice, as was demonstrated in combination of sanroque and 
IFN-γ receptor (Ifngr) knockout genotypes (46). At this point, it 
is not clear how IFN-γ becomes induced in sanroque mice, since 
the Ifng mRNA is rather strongly regulated by AU-rich elements 
(AREs), which are recognized by ARE-binding proteins like TTP, 
AUF, or HUR proteins, and genetic deletion of these AREs has 
been demonstrated to also cause a lupus-like phenotype in mice 
(47, 48). As compared to sanroque mice, CD4+ T  cells lacking 
Roquin proteins also did not show a similarly strong Th1 bias, 
but rather differentiated into Th17 cells in vitro, a phenotype that 
developed in addition to the shared spontaneous differentiation 
into Tfh cells (20). This differential bias may relate to a partial or 
complete derepression of the different Roquin-regulated targets 
including ICOS, Irf4, cRel, Nfkbiz, and Nfkbid that have been 
shown to affect Tfh as well as Th17 differentiation (49–58). One 
key signaling cascade influenced by Roquin has been identified 
in the PI3K-Akt-mTOR and Foxo1 pathway in which Roquin 
regulates the expression of ICOS, Pten, and Itch mRNAs (19, 
31, 44) (Figure  2). The ICOS and Itch mRNAs are bound and 
negatively regulated, leading to increased ICOS and Itch levels in 
the absence of Roquin (19, 28, 31, 38). Increased ICOS expression 
FiGURe 2 | Regulation of T follicular helper cell differentiation and function by major RNA-binding proteins and microRNAs. Abbreviations: TCR, T cell receptor.
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and signaling stimulates PIP3 formation that activates the kinase 
Akt, which phosphorylates and thereby inactivates Foxo1, a 
transcription factor that strongly inhibits Tfh differentiation 
(57). In contrast, elevation of Itch, a Foxo1-specific E3 ubiquitin 
ligase, decreases cellular levels of Foxo1 (57, 59). Different from 
the other Roquin targets, Pten levels decreased in CD4+ T cells 
and Treg cells upon induced ablation of Roquin-encoding alleles 
(19). Interestingly, the Roquin-bound sequences in the 3′ UTR of 
Pten showed conservation of those nucleotides that were involved 
in forming a stem-loop (19), but at the same time overlapped 
with a miR-17 binding site, which was previously shown to effec-
tively regulate Pten levels in T cells (60). Biochemical evidence 
showed that Ago2 more efficiently associated with Pten mRNA 
in the absence of Roquin (19), suggesting a structure switch 
mode within this cis-element and a competitive interaction and 
regulation of Pten mRNA by Roquin and miR-17–92 containing 
RNA-induced silencing complex (miRISC) transacting factors. 
The regulation of PI3K-Akt-mTOR and Foxo1 signaling through 
Roquin-mediated regulation of ICOS, Itch, and Pten targets not 
only contributes to the observed skewing of T cell differentiation 
into Tfh and Th17 and against induced Treg (iTreg) cell differen-
tiation, but also correlates with a conversion of thymus-derived 
Treg cells into Tfr cells in vivo (19). Roquin-deficient Treg cells 
lost CD25 expression, upregulated a Tfh but downregulated 
their Treg gene signature and retained their ability to control 
antigen-dependent GC B cell responses and affinity maturation 
of antibodies. In contrast, Roquin-deficient Treg cells were less 
able to prevent spontaneous activation of CD4+ and CD8+ T cells 
and to protect from T cell transfer-induced colitis (19).
ReGNASe-1
Regnase-1 was initially described as an LPS-induced gene and 
the knockout of Regnase-1 caused a severe auto-inflammatory 
phenotype in mice. The molecular basis for this phenotype was 
proposed to involve Regnase-1-dependent regulation of IL-6 and 
IL-12p40 regulation in myeloid cells (34). However, more recently, 
it was shown that the combined knockout of Regnase-1 with IL-6 
or IL-12-encoding alleles did not fully rescue central phenotypes. 
Instead, conditional T cell-specific deletion of Regnase-1 pheno-
copied most of the phenotypes of the global Regnase-1 knockout 
(21). The consequences of Regnase-1 deficiency for Tfh differ-
entiation have not been experimentally addressed so far, but the 
following observations could argue for a control of Tfh differentia-
tion by Regnase-1: First, upon genetic inactivation of Regnase-1 
globally or specifically in T cells, mice develop autoantibodies and 
show elevated plasma cell levels as well as an accumulation of all 
immunoglobulin isotypes in their sera (21, 34). Second, at least 
for the regulation of a CDE-containing element in the 3′ UTR of 
the Tnf mRNA, Regnase-1 has been demonstrated to function-
ally cooperate with Roquin in target regulation, and this mode of 
direct or indirect interaction may apply to several other shared 
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target mRNAs that have an effect on Tfh cell differentiation (20, 
37). Moreover, the systemic IFN-γ production that was found to 
drive Tfh cell differentiation in sanroque mice (46) was similarly 
observed upon deletion of Regnase-1-encoding alleles in T cells 
(18, 21). Finally, among the targets that have been reported to be 
regulated by Regnase-1 are several gene products that are known 
to promote Tfh differentiation, including ICOS, Ox40, and IL-6 
(2, 61). Future experiments should demonstrate how Regnase-1 
or other Regnase paralogs affect Tfh cell differentiation in a T cell-
intrinsic or extrinsic manner.
POSTTRANSCRiPTiONAL GeNe 
ReGULATiON BY miRNAs iN T CeLLS
MicroRNAs are small endogenously expressed RNAs that regulate 
gene expression. Each miRNA can have several hundred target 
genes and a given mRNA might in turn be regulated by many dif-
ferent miRNAs simultaneously. These features of miRNAs result 
in redundancy that is believed to buffer gene expression and to 
confer biological robustness (62–64). In line with this, miRNAs 
and the miRNA-induced silencing complex (miRISC) are rela-
tively highly expressed in naïve CD4+ T cells, thereby contribut-
ing to the prevention of spontaneous differentiation into effector 
cells (65, 66) (Figure 1). In activated T cells, most miRNAs are 
downregulated, while only a few so-called driver-miRNAs are 
differentially upregulated to act in concert with transcription 
factors for proper T helper cell differentiation and function 
(67–71) (Figure 1). Initial experiments that utilized genetically 
engineered mice in which T cells lacked mature miRNAs due to 
ablation of miRNA-processing proteins such as Dicer established 
functional roles for miRNAs in the generation of Th1, Th2, Th17, 
and Treg cells (72, 73). While all these T helper cell populations 
could still be generated to various degrees from miRNA-deficient 
naïve CD4+ precursor cells, global miRNA expression in CD4+ 
T  cells was absolutely required for the differentiation of naïve 
CD4+ T cells into mature Tfh cells in vivo (74). To date, various 
T cell-expressed miRNAs and miRNA clusters have been shown 
to play critical roles in the differentiation and function of Tfh  
cells (69) and in the establishment and maintenance of GCs (75), 
and these findings indicate that Tfh cells may be particularly 
sensitive to the regulation by miRNAs.
miRNA-MeDiATeD ReGULATiON OF Tfh 
AND Tfr CeLLS
Among the individual miRNAs that have been studied in the 
context of Tfh cells, the function of the miR-17–92 cluster and 
the miR-155/miR-146a axis have been investigated in most detail 
and will be described here (Figure 2).
THe miR-17–92 CLUSTeR
The miR-17–92 cluster consists of six individual miRNAs that can 
be grouped into four distinct miRNA families according to their 
seed sequences (76). Even though miR-17–92 is transcribed as a 
common transcript and highly induced in activated CD4+ T cells 
(65, 77–80) (Figure 1), the individual miRNA cluster members 
are differentially processed thereafter (81). miR-17–92 is not only 
critically involved in the regulation of Tfh cells (as discussed in 
more detail below), but it is also important for the differentiation 
and function of other T helper cell subsets [reviewed in Ref. (82)], 
including Th1 (80, 83), Treg (77, 83), Th2 (84), and Th17 cells 
(79, 85). Interestingly, miR-17–92 shares several features between 
Th2 cells and type 2 innate lymphoid cells (86), indicating that 
many of the miR-17–92 cluster’s functions may be conserved 
between the individual T helper cell subsets and their respec-
tive ILC counterparts. First evidence for a role of miR-17–92 
in Tfh cells (Figure 1) came from an early study in which Bcl6 
overexpression resulted in reduced miR-17–92 expression, with 
miR-17–92 itself repressing CXCR5 (87). However, more recent 
studies clarified the Tfh-promoting function of miR-17–92 
(74, 78, 80). Deletion of the miR-17–92 cluster in T  cells 
resulted in reduced Tfh cell differentiation, whereas transgenic 
overexpression of the cluster resulted in higher frequencies and 
numbers of Tfh cells. On the mechanistic level, miR-17–92 was 
found to target Pten and Phlpp2, a phosphatase in the ICOS 
signaling pathway (74, 78). Besides these Tfh-promoting effects, 
miR-17–92 also prevented the expression of genes that are nor-
mally not associated with Tfh cells during LCMV infection, but 
instead are usually associated with Th17  cells, including Ccr6, 
Rora, Il22, Il1r1, and Il1r2 (74). Importantly, it was further shown 
that each miRNA of the miR-17–92 cluster directly targeted the 
Rora 3′ UTR and that this axis contributed to repressing the 
Th17-associated gene expression program in wild-type Tfh cells 
(74). Since most of these experiments were performed with mice 
deficient in or overexpressing the entire miR-17–92 cluster in 
T cells in vivo, not much is known about the contribution of the 
individual miRNAs of this cluster to Tfh cell differentiation and 
function. This would be important though, because individual 
miRNAs of this cluster can have cooperative but also opposing 
effects on T cells, which is further amplified by the complexity 
of the downstream target gene networks. The continuing lack of 
reliable protocols for the in  vitro differentiation of murine Tfh 
cells (2) currently impairs the ability to perform in vitro experi-
ments that interrogate individual miRNA functions specifically 
in mouse Tfh cells. Nevertheless, recent technological advances 
such as CRISPR/Cas9 or mouse lines that lack individual cluster 
members (88) might substitute for this current limitation. Using 
human Tfh cell in vitro cultures, a recent report found that miR-
92a targets KLF2 and PTEN, thereby promoting Tfh cell differ-
entiation (89). Similar to Tfh cells, Tfr cells are also responsive to 
the dose of miR-17–92 regulation (74). As a first example of how 
RBPs can intersect with miRNA-dependent gene regulation of 
Tfh differentiation, it was recently shown that Roquin (see above) 
interferes with miR-17–92 binding to an overlapping cis-element 
in the Pten 3′ UTR, which leads to inhibition of the PI3K–Akt–
mTOR signaling pathway, thereby inhibiting the conversion of 
Treg to Tfr cells (19).
THe miR-155/miR-146a AXiS
Similar to miR-17–92, miR-155 is induced and highly expressed 
in activated T helper cells (65, 90–93) (Figure 1). miR-155 has 
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been shown to be important for proper differentiation of Th1 
and Th17 cells and for EAE pathogenesis (94–96), as well as for 
Treg differentiation and function (97, 98). In contrast to miR-155, 
miR-146a is highly expressed in naïve CD4+ T cells and initially 
downregulated in activated T cells (65, 90) (Figure 1). miR-146a 
is subsequently upregulated in differentiating Tfh cells (55), 
reaching the highest expression levels among hematopoietic 
cells in mature Tfh and GC B  cells (99). In comparison to the 
total numbers of Tfh cells elicited during an immune response, 
the kinetics of increased miR-146a expression slightly lagged 
behind (55). These data indicate that miR-146a acts as a negative 
regulator of Tfh cells that prevents excessive Tfh cell numbers 
and thereby limits GC responses (69). In T cells, an epistatic rela-
tionship between miR-146a and miR-155 has been described in 
which miR-155 promotes and miR-146 inhibits IFNγ responses 
(100). Further studies have also established a role for miR-146a in 
T cell activation (101, 102) as well as in differentiation and func-
tion of different T helper cell subsets, including Th1, Th17, and 
Treg cells (103–106). miR-146a-deficient mice develop a chronic 
inflammatory phenotype with progressive myeloproliferation 
and eventually myeloid and lymphoid malignancies (107). In 
these mice, Tfh cells accumulate due to the Tfh cell-promoting 
function of miR-155 (see below), thus further highlighting the 
reciprocal regulation of Tfh cell differentiation by these two 
miRNAs (108). Mechanistically, miR-146a was found to repress 
several Tfh-associated genes, including ICOS, which was highly 
upregulated in miR-146a-deficient CD4+ T cells (55). miR-146a 
itself is also regulated by Roquin (43). In a different study, it was 
shown that miR-155 promoted Tfh cell differentiation by repress-
ing the expression of Peli1, a ubiquitin ligase that promotes the 
degradation of the NF-κB family transcription factor c-Rel, which 
itself controls cellular proliferation and CD40L expression (109). 
Another study found that miR-155 expression in hematopoietic 
cells was required for the differentiation of Tfh and GC B cells 
following murine gammaherpesvirus infection (110). Together, 
these data indicate a tightly controlled reciprocal function of 
miR-155 and miR-146a in the regulation of Tfh cell differentia-
tion and function.
CONCLUSiON
T follicular helper cells require continuous stimulation (111, 112) 
and the differentiation of these cells is more dependent on cos-
timulatory signals than other T helper cell subsets (113). This 
might be the reason for why they are so responsive to the regu-
lation by RBPs and miRNAs. Both classes of trans-acting factors 
cooperate to shape the expression levels not only of costimula-
tory molecules but also of intracellular transducers of signals 
in the PI3K-Akt-mTOR and Foxo1 pathway (Figure 2). PI3K 
activity is strongly stimulated by ICOS co-stimulation as well 
as TCR signaling and was shown to drive the Tfh differentiation 
program (114). Besides the well-established miRNA regulators 
of Tfh cells, the miR-17–92 cluster and the miR-155/miR-146a 
axis, other miRNAs may also play important roles in Tfh cell dif-
ferentiation and T helper cell plasticity. For example, miR-10a is 
highly expressed in Treg cells (99, 115, 116). TGF-beta induced 
miR-10a represses the Tfh-associated transcriptional repressor 
Bcl6, thereby preventing the conversion of Treg cells into Tfh 
cells (116). In human Tfh cells, miR-31 was recently shown to be 
downregulated by BCL6, thereby resulting in the upregulation 
of the miR-31 target mRNAs encoding the Tfh-associated mol-
ecules CD40L, SAP, and BTLA (117). The finding that Tfh cell 
differentiation is completely blocked in miRNA-deficient CD4+ 
T cells (74) further indicates that additional miRNAs must play 
important roles in Tfh cell biology. Moreover, it remains largely 
unclear in how far miRNAs and their target gene networks 
contribute to the function and maintenance of Tfh cells. It is 
also likely that upon comprehensive identification of RBPs that 
are bound to mRNAs in T  cells and upon individual testing 
of these factors, additional contributions of RBPs in T  cell 
differentiation will be uncovered. Such future investigations 
will provide novel insights into how the loss of individual 
miRNAs or individual RBPs affects T cell differentiation pro-
grams. Additional contributions may result from other levels 
of posttranscriptional regulation such as alternative splicing, 
alternative polyadenylation, or RNA modifications, which have 
already been shown to regulate Tfh-relevant genes (118–120), 
albeit, it has not yet been tested how these processes may impact 
Tfh differentiation. Another big task will be to understand how 
simultaneous inputs from different posttranscriptional regula-
tors generate a specific response. Here, it will be critical to 
comprehensively identify and dissect all cis-elements encoded in 
mRNAs with strong impact on T cell differentiation programs 
(Figure 2). These analyses should be combined with structural 
and biochemical information to integrate the emerging evidence 
of RNA-modifications, to describe dynamics of RNA/protein-
complex formation, and to understand how the individual 
binding sites act redundantly, cooperatively, antagonistically, 
or synergistically in posttranscriptional gene regulation, thus 
enabling cell-fate decisions.
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